Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Philip P Storey , MD

Ophthalmology • Austin, TX

Active NPI 1053614453 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

801 W 38th St Ste 200
Austin, TX 787051169

Call 5124510103 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

801 W 38th St Ste 200

Austin, TX 787051169

Telephone 5124510103
Fax 5124512741
Organization at the Same NPPES Address or Phone
Austin Retina Associates Pllc Facility NPI 1114999828

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 1 group name: Austin Retina Associates Pllc. See the list

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Medical School

Johns Hopkins University School Of Medicine

Graduation Year

2012

Medicare patients

1,075 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $5,114,309 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $4,044,479 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

611 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$8,771 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $31,275.05 across 43 records.

By nature of payment (3 largest of 4)

  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $23,647.31 across 5 records.
  • Consulting Fee: $5,046.00 across 3 records.
  • Food and Beverage: $1,421.14 across 31 records.

Reporting-company totals (3 largest of 11)

  • Regeneron Pharmaceuticals, Inc.: $18,633.65 across 20 records.
  • Genentech, Inc.: $6,748.13 across 4 records.
  • Apellis Pharmaceuticals, Inc.: $2,769.75 across 5 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

14 years (graduated 2012)

CMS Doctors and Clinicians data list 2012 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

NPI first issued

2010

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Storey has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Storey as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Austin and Texas

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Austin, TX (2024, 76 clinicians with data). Median for this group: 1,237. Middle half: 389 to 2,405.

More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: 1,763. Middle half: 750 to 3,589.

Medicare-allowed amount

A higher Medicare-allowed amount than 95% of clinicians listed under Ophthalmology in Austin, TX (2024, 76 clinicians with data). Median for this group: $154,147. Middle half: $61,098 to $361,316.

A higher Medicare-allowed amount than 95% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: $212,221. Middle half: $85,606 to $414,307.

Paid by Medicare

A higher Medicare payment amount than 95% of clinicians listed under Ophthalmology in Austin, TX (2024, 76 clinicians with data). Median for this group: $114,451. Middle half: $42,558 to $262,908.

A higher Medicare payment amount than 95% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: $152,383. Middle half: $60,170 to $300,692.

Medicare Part D prescriptions

Close to the middle for clinicians listed under Ophthalmology in Austin, TX (2024, 81 clinicians with data). Median for this group: 339. Middle half: 162 to 916.

Fewer Part D prescriptions than 65% of clinicians listed under Ophthalmology in Texas (2024, 1,065 clinicians with data). Median for this group: 915. Middle half: 319 to 2,161.

Part D drug cost

A lower Part D drug cost than 60% of clinicians listed under Ophthalmology in Austin, TX (2024, 81 clinicians with data). Median for this group: $31,473. Middle half: $4,573 to $150,313.

A lower Part D drug cost than 80% of clinicians listed under Ophthalmology in Texas (2024, 1,065 clinicians with data). Median for this group: $73,842. Middle half: $14,153 to $240,871.

111 active clinicians are listed under Ophthalmology with a practice address in Austin, TX (1,514 in Texas).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Austin

0% of these 111 clinicians have the CMS telehealth indicator.

71.2% of these 111 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 43 records totaling $31,275.05.

Manufacturer Payment Nature Product Type Amount ($)
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $7,520.00
Genentech, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
Vabysmo General $6,720.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $5,640.00
Apellis Pharmaceuticals, Inc.
Consulting Fee
Cash or cash equivalent
Syfovre General $2,646.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $2,216.31
Ocular Therapeutix, Inc.
Consulting Fee
Cash or cash equivalent
— General $1,600.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $1,551.00
Ocular Therapeutix, Inc.
Consulting Fee
Cash or cash equivalent
— General $800.00
Regeneron Pharmaceuticals, Inc.
Travel and Lodging
In-kind items and services
EYLEA HD General $526.71
Regeneron Pharmaceuticals, Inc.
Travel and Lodging
In-kind items and services
EYLEA HD General $402.92
BIOTISSUE HOLDINGS INC.
Food and Beverage
In-kind items and services
— General $175.64
Regeneron Pharmaceuticals, Inc.
Travel and Lodging
In-kind items and services
EYLEA HD General $164.65
Genentech, Inc.
Food and Beverage
In-kind items and services
Vabysmo General $149.99
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
EYLEA HD General $149.99
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
EYLEA HD General $123.38
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
EYLEA HD General $108.49
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
EYLEA HD General $98.20
Regeneron Pharmaceuticals, Inc.
Travel and Lodging
In-kind items and services
EYLEA HD General $66.32
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
EYLEA HD General $44.03
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
EYLEA HD General $43.60
Apellis Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
Syfovre General $33.93
Apellis Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
Syfovre General $33.83
ANI Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
YUTIQ General $31.95
Astellas Pharma US Inc
Food and Beverage
In-kind items and services
Izervay General $30.84
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
EYLEA HD General $30.46

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
J2777 Injection, faricimab-svoa, 0.1 mg
9,000 35 $84.00 $34.29
J2781 Injection, pegcetacoplan, intravitreal, 1 mg
7,605 65 $336.00 $147.02
Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
5,424 220 $1000.55 $226.73
J2782 Injection, avacincaptad pegol, 0.1 mg
3,600 39 $250.00 $108.59
92134 Imaging of retina
2,258 818 $125.00 $40.22
67028 Injection of drug into eye
1,769 459 $550.00 $135.05
J0177 Injection, aflibercept hd, 1 mg
1,472 48 $693.75 $332.23
J0178 Injection, aflibercept, 1 mg
892 135 $2000.00 $821.29
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
442 358 $200.00 $91.97
92250 Photography of the retina
432 293 $95.00 $36.82
92235 Exam of retinal blood vessels using a special camera after injection of a dye
344 317 $270.00 $160.36
92014 Established patient complete exam of visual system
241 230 $265.00 $126.51
92004 New patient complete exam of visual system
154 154 $315.00 $148.90
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
126 126 $350.00 $170.28
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
97 87 $270.00 $127.52
J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg
91 11 $400.00 $202.31
76512 2d ultrasound scan of eye tissue and structures
79 49 $150.00 $47.87
J9035 Injection, bevacizumab, 10 mg
75 33 $150.00 $67.35
J3490 Unclassified drugs
52 33 $5238.94 $2511.57
92012 Established patient problem focused exam of visual system
45 45 $190.00 $87.12
J3590 Unclassified biologics
40 21 $5000.00 $2128.48
67036 Removal of eye fluid (vitreous) between lens and retina
32 27 $1820.00 $853.43
67145 Photocoagulation treatment to prevent detachment of retina
27 27 $750.00 $228.77
67042 Removal of membrane of retina with removal of internal limiting membrane of retina
15 15 $2310.00 $1092.61
67108 Repair of detached retina with drainage and removal of eye fluid between lens and retina
15 15 $2405.00 $1182.01

(top 25 shown)

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha 130 2,632 $1,398.60 105
Prednisolone Acetate Prednisolone Acetate 81 3,782 $3,242.98 52
Ketorolac Tromethamine Ketorolac Tromethamine 70 2,104 $2,231.61 44
Timolol Maleate Timolol Maleate 44 2,528 $397.29 30
Brimonidine Tartrate Brimonidine Tartrate 25 1,127 $394.01 20
Dorzolamide Hcl Dorzolamide Hcl 25 1,840 $309.91 16
Atropine Sulfate Atropine Sulfate 20 1,245 $636.42 13
Latanoprost Latanoprost 17 940 $160.36 11

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Ophthalmology Primary Specialty

NUCC Taxonomy Code: 207W00000X

License # reported to NPPES TX S2177

An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.

Ophthalmology - Retina Specialist

NUCC Taxonomy Code: 207WX0107X

License # reported to NPPES TX S2177

An ophthalmologist who specializes in the diagnosis and treatment of vitreoretinal diseases.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Texas Medical Board.
Look Up on State Board Site

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - OPHTHALMOLOGY

Medicare Enrollment ID

I20190618003415

Enrollment State Jurisdiction

TX

PECOS Control ID

4183992027

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Austin Retina Associates Pllc

801 W 38th St, Austin, TX 787051169

Phone: 5124510103

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

17 listed
NPI 1891290797

MDPHD

NPI 1962474643

Doctor of Medicine (M.D.)

NPI 1588788830

Doctor of Medicine (M.D.)

NPI 1013989706

Doctor of Medicine (M.D.)

NPI 1518586866

Doctor of Medicine (M.D.)

Dr. Marco Ji , MD

Ophthalmology

NPI 1811525777

Doctor of Medicine (M.D.)

Career & Practice History Timeline

Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status

15 Historical Events
📍
Updated Practice Location July 08, 2019

Registered at 801 W 38TH ST STE 200, AUSTIN, TX 787051169 (Tel: 5124510103)

📍
Updated Business Mailing Address July 08, 2019

Registered at 801 W 38TH ST STE 200, AUSTIN, TX 787051169 (Tel: 5124510103)

👤
Provider Name / Credentials Updated July 08, 2019

Recorded as PHILIP STOREY, MD

🎓
Medical Taxonomy / Specialty Registered (Primary Specialty) July 08, 2019

Ophthalmology (license number reported to NPPES: TX S2177)

✅
NPI Profile Active September 07, 2017

NPI status registered as active in NPPES database

📍
Updated Practice Location September 07, 2017

Registered at 840 WALNUT ST STE 1020, PHILADELPHIA, PA 191075109 (Tel: 8003316634)

📍
Updated Business Mailing Address September 07, 2017

Registered at MID ATLANTIC RETINA, 4060 BUTLER PIKE, SUITE 200, PLYMOUTH MEETING, PA 19462 (Tel: 8003316634)

👤
Provider Name / Credentials Updated September 07, 2017

Recorded as PHILIP STOREY

🎓
Medical Taxonomy / Specialty Registered (Primary Specialty) September 07, 2017

Ophthalmology (license number reported to NPPES: PA MD460579)

✅
NPI Profile Active May 09, 2011

NPI status registered as active in NPPES database

📍
Practice Location (Initial Record) May 09, 2011

Registered at THE JOHNS HOPKINS HOSPITAL, 600 NORTH WOLF STREET, BALTIMORE, MD 212870001 (Tel: 4109555000)

📍
Business Mailing Address (Initial Record) May 09, 2011

Registered at THE JOHNS HOPKINS HOSPITAL, 600 NORTH WOLF STREET, BALTIMORE, MD 212870001 (Tel: 4109555000)

👤
Provider Name / Credentials (Initial Record) May 09, 2011

Recorded as PHILIP STOREY

🎓
Medical Taxonomy / Specialty Registered (Primary Specialty) May 09, 2011

Student in an Organized Health Care Education/Training Program

🟢
Initial NPI Registration & Enumeration December 07, 2010

First registered as active Individual Practitioner in NPPES Database.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1053614453
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: December 07, 2010
Last Update: July 08, 2019
Sole Proprietor: Yes

Other Ophthalmology Specialists in Austin

All Ophthalmology Specialists in Austin

More public profiles in Texas

Directory navigation, in NPI number order.

Mailing Address

801 W 38th St Ste 200

Austin, TX 787051169

Phone: 5124510103

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.